Yoshida, Reiko
Kaneyasu, Tomoko
Ueki, Arisa
Yamauchi, Hideko
Ohsumi, Shozo
Ohno, Shinji
Aoki, Daisuke
Baba, Shinichi
Kawano, Junko
Matsumoto, Naomichi
Nagasaki, Masao
Ueno, Takayuki
Inari, Hitoshi
Kobayashi, Yusuke
Takei, Junko
Gotoh, Osamu
Nishi, Mitsuyo
Okamura, Miki
Kaneko, Keika
Okawa, Megumi
Suzuki, Misato
Amino, Sayuri
Inuzuka, Mayuko
Noda, Tetsuo
Mori, Seiichi http://orcid.org/0000-0001-8569-4504
Nakamura, Seigo
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP16cm0106503, JP17cm0106503, JP18cm0106503, JP19cm0106503, JP20cm0106503, JP21cm0106503)
Article History
Received: 26 December 2023
Accepted: 8 July 2024
First Online: 13 July 2024
Declarations
:
: Dr. Takayuki Ueno is the Editor-in-Chief of <i>BreastCancer</i>. Other authors have no conflict of interest.
: Approval of the research protocol by an Institutional Reviewer Board: This study was approved by the internal review board (IRB) at each of 6 institutions. The main IRB was Showa University IRB.
: Written informed consent was obtained from all participants (probands, BRs, and spouses).